iCAD and Hitachi ink distribution agreement

iCAD and Hitachi Medical Systems have reached a distribution agreement covering iCad's breast MR image analysis software and Hitachi's MR systems.

According to the agreement, iCAD’s SpectraLook with PrecisionPoint image analysis software for breast MRI will be available for purchase with Hitachi’s Oasis 1.2T and Echelon 1.5T MRI systems.

The addition of iCAD’s technologies will give radiologists more control, accuracy and faster workflow, according to Twinsburg, Ohio-based Hitachi. The technology is also designed to assist radiologists in distinguishing potential cancers in the breast as part of their overall analysis of MRI studies and streamline the planning and performance of MRI-guided percutaneous breast biopsies.

SpectraLook with PrecisionPoint will also be available as an upgrade to current customers, according to Nashua, N.H.-based iCad.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.